title: Evaluation of diagnostic value of procalcitonin as a marker of neonatal bacterial infections.
abstract: OBJECTIVE
  This study tried to assess sensitivity, specificity, positive and negative predictive value of procalcitonin for diagnosis of neonatal bacterial infections.
  
  
  METHODS
  This prospective cross sectional study was carried out during an 18-month period in NICU and neonatal wards of Besat Hospital in Hamedan province, Iran. 39 symptomatic infants with clinical and laboratory findings in favor of bacterial infection with a positive blood, CSF, and/or supra pubic urine culture entered the study; 32 newborns without any bacterial infection served as control group. Quantitative procalcitonin level ≥0.5 ng/ml was accepted as pathological. Finally sensitivity, specificity, positive (PPV) and negative predictive value (NPV) were calculated for procalcitonin test.
  
  
  RESULTS
  20 blood cultures, 17 urine cultures and 8 CSF cultures were positive. Sensitivity, specificity, PPV and NPV for procalcitonin test was 76.9%, 100%, 100% and 78% respectively. Diagnostic value of procalcitonin test in accordance with blood culture for mentioned items was 85%, 100%, 100% and 91.4% respectively. Its diagnostic value according to urine culture was: sensitivity 70.6%, specificity 100%, PPV 100% and NPV 86.4%, and according to CSF culture was: sensitivity 75%, specificity 100%, PPV 100% and NPV 94.1% respectively.
  
  
  CONCLUSIONS
  The results show that the procalcitonin test has high sensitivity, specificity, PPV and NPV for diagnosis of neonatal infections.
authors: Pathology department, Hamadan University of Medical Sciences, Hamadan, Iran.
authors: Alireza
authors: A
authors: Monsef
authors: Fatemeh
authors: F
authors: Eghbalian
keywords: Infection; Newborn; Predictive Value of Tests; Procalcitonin; Sensitivity; Specificity
references: Int J Antimicrob Agents. 2002 Jul;20(1):1-9
references: 12127705
references: Ginekol Pol. 2004 Jun;75(6):439-44
references: 15524419
references: An Pediatr (Barc). 2006 Apr;64(4):341-8
references: 16606571
references: Intensive Care Med. 2001 Jan;27(1):211-5
references: 11280637
references: Clin Infect Dis. 2004 Jul 15;39(2):206-17
references: 15307030
references: Przegl Lek. 2002;59 Suppl 1:46-9
references: 12108072
references: Eur J Pediatr. 2001 Feb;160(2):95-100
references: 11271398
references: J Trop Pediatr. 2002 Feb;48(1):10-4
references: 11866330
references: Turk J Pediatr. 2007 Jan-Mar;49(1):21-9
references: 17479640
references: Physiol Res. 2000;49 Suppl 1:S57-61
references: 10984072
references: Crit Care. 2004 Feb;8(1):R12-20
references: 14975050
references: S Afr Med J. 2004 Oct;94(10):851-4
references: 15532763
references: Medicina (Kaunas). 2006;42(1):69-78
references: 16467616
references: BMC Pediatr. 2007 Feb 26;7:9
references: 17324267
references: Crit Care Med. 2000 Apr;28(4):977-83
references: 10809269
references: Eur J Clin Microbiol Infect Dis. 2003 Jun;22(6):377-8
references: 12750960
references: Mymensingh Med J. 2006 Jan;15(1):108-14
references: 16467776
references: BMC Pediatr. 2006 May 18;6:16
references: 16709255
references: Crit Care. 2005 Aug;9(4):R344-50
references: 16137346
references: Intensive Care Med. 2000 Sep;26(9):1193-200
references: 11089742